Application of an integral scale for diagnosing primary hyperparathyroidism with an assessment of the probability of disease development: a case report

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

To improve the efficacy of primary hyperparathyroidism (PHPT) diagnosis and probability assessment, we developed the “Automated System for the Diagnosis of Primary Hyperparathyroidism and Dynamic Assessment of Phosphorus–Calcium Metabolism (PHPTCalculator),” which was tested at the Samara State Medical University clinics. During validation, the PHPTCalculator correctly diagnosed PHPT in all 68 patients, which was subsequently confirmed by surgical findings.

Here, we present a 47yearold male patient (R.) who presented with dizziness, weakness, and joint pain. Ultrasound revealed a right parathyroid adenoma and left parathyroid hyperplasia. Before surgery, the PHPTCalculator estimated the probability of PHPT at 100%. The patient underwent selective parathyroidectomy with removal of the lower parathyroid glands. Histopathology confirmed a chiefcell parathyroid adenoma. Three months after surgery, joint pain persisted, and parathyroid hormone (PTH) was 78 pg/mL. Although ultrasound and scintigraphy showed no abnormal parathyroid glands, the PHPTCalculator estimated the probability at 75%. The patient underwent a second surgery: bilateral neck exploration and removal of the upper hyperplastic parathyroid gland. Histopathology again confirmed a chiefcell parathyroid adenoma. Three months after the second surgery, the patient was asymptomatic, and the estimated probability was 25%, supported by normalization of PTH, total and ionized calcium, and serum phosphorus.

Thus, the proposed PHPT diagnostic scale showed high diagnostic value and may serve as an additional diagnostic tool in this patient population.

Full Text

Restricted Access

About the authors

Igor V. Makarov

Samara State Medical University

Author for correspondence.
Email: i.v.makarov@samsmu.ru
ORCID iD: 0000-0002-1068-3330
SPIN-code: 8082-9510

MD, Dr. Sci. (Medicine), Professor, Head, Depart. of General Surgery and Surgical Diseases

Russian Federation, Samara

Bogdan V. Krivosheev

Samara State Medical University

Email: b.v.krivosheev@samsmu.ru
ORCID iD: 0009-0002-0548-9717
SPIN-code: 6443-2271

postgraduate student, Depart. of General Surgery and Surgical Diseases

Russian Federation, Samara

Evgeny S. Lopukhov

Samara State Medical University

Email: e.s.lopuhov@samsmu.ru
ORCID iD: 0009-0001-5894-3197
SPIN-code: 6862-7628

Head, Surgical Depart. No. 1 of the Propaedeutic Surgery Clinic

Russian Federation, Samara

Roman A. Gusev

Samara State Medical University

Email: romka-gusev2011@yandex.ru
ORCID iD: 0009-0008-9884-1110
SPIN-code: 2168-8934

student, Institute of Pediatrics

Russian Federation, Samara

References

  1. Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993–4004. doi: 10.1210/jc.2018-01225 EDN: RUQIVD
  2. Niyazova NF. Primary hyperparathyroidism: ways of solution. Endocrinology: News, Opinions, Training. 2023;12(1):39–47. doi: 10.33029/2304-9529-2023-12-1-39-47 EDN: AOFILP
  3. Makarov IV, Prokofieva NA, Sidorov AYu, Golubova VM. Methods of Laboratory Integral Assessment of Phosphorus-Calcium Metabolism in the Diagnosis of Primary Hyperparathyroidism. Surgery News. 2022;30(2):152–161. doi: 10.18484/2305-0047.2022.2.152 EDN: QPVIAK
  4. Mokrysheva NG, Mirnaya SS, Dedov II, et al. Primary hyperparathyroidism in Russia according to registry data. Problems of endocrinology. 2019;65(5):300–310. doi: 10.14341/probl10126 EDN: ZPKFMC
  5. Nikitina TP, Gladkova IN, Rusakov VF, et al. Quality of life of patients with primary hyperparathyroidism after surgical treatment. Problems of endocrinology. 2022;68(1):27–39. doi: 10.26442/00403660.2021.10.201109 EDN: FLBZLF
  6. Bilezikian JP, Khan AA, Silverberg SJ. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. International Workshop on Primary Hyperparathyroidism. J Bone and Mineral Res. 2022;37(11):2293–2314. doi: 10.1002/jbmr.4677 EDN: QHOWZU
  7. Yanevskaya LG, Karonova TL, Sleptsov IV, et al. Primary hyperparathyroidism: clinical forms and their features. Results of a retrospective study. Clinical and experimental thyroidology. 2019;15(1):19–29. doi: 10.14341/ket10213 EDN: LKPZHH
  8. Gorbacheva AM, Eremkina AK, Mokrysheva NG. Hereditary syndromal and non-syndromic forms of primary hyperparathyroidism. Problems of endocrinology. 2020;66(1):23–34. doi: 10.14341/probl10357 EDN: SYDHWW
  9. Mokrysheva NG, Eremkina AK, Kovaleva EV, et al. Modern problems of hyper- and hypoparathyroidism. Therapeutic archive. 2021;93(10):1149–1154. doi: 10.26442/00403660.2021.10.201109 EDN: ZGICRX
  10. Egshatyan LV. Non-classical effects of vitamin D. Obesity and metabolism. 2018;15(1):12-18. doi: 10.14341/OMET2018112-18 EDN: XQZQIP
  11. Mokrysheva NG, Eremkina AK, Mirnaya SS, et al. Clinical guidelines for primary hyperparathyroidism, short version. Problems of endocrinology. 2021;67(4):94–124. doi: 10.14341/probl12801 EDN: GKEEJB
  12. Patent RUS № 2856588/24.02.2026. Makarov IV, Krivosheev BV, Lopukhov ES. Method for determining the likelihood of developing primary hyperparathyroidism. (In Russ.) EDN: FYALNH
  13. Makarov IV, Prokofieva NA, Lopukhov ES, Krivosheev BV. Therapeutic and diagnostic algorithm for the management of patients with primary hyperparathyroidism. Pediatrician. 2025;16(2):40–47. doi: 10.56871/PED.2025.27.75.004 EDN: ZNEOGX
  14. Patent RUS № 2730997/26.08.2020. Makarov IV, Sidorov AYu, Prokofieva NA, et al. Method of diagnosis of primary hyperparathyroidism. (In Russ.) EDN: ZZQTNF
  15. Patent RUS № 2730999/26.08.2020. Makarov IV, Sidorov AYu, Prokofieva NA, et al. A method of biochemical diagnosis of primary hyperparathyroidism. (In Russ.) EDN: RIKASO

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2026 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07